Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

Join BlackDoctor.org's CMO, Derrick Lane, and a panel of experts for a crucial conversation exploring "Obesity as a Disease." ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success ...

I’m Kelly Grant, a health reporter with The Globe and Mail. Yesterday, the Canadian Medical Association Journal published the first new guideline on the treatment of childhood obesity in nearly 20 ...

New research to be presented at the European Congress on Obesity (ECO 2025) suggests that focusing on percentage weight loss ...